Human and mouse granzyme A induce a proinflammatory cytokine response

Sunil S Metkar1, Cheikh Menaa, Julian Pardo

  • 1Department of Medicine, NorthShore University HealthSystem Research Institute, Evanston, IL 60201, USA.

Immunity
|October 28, 2008
PubMed

Insights

Granzyme A (GzmA) causes rapid cell death via membrane damage, even without its catalytic activity. GzmA also triggers inflammatory cytokine release, highlighting its unexpected role in inflammation.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Granzyme A (GzmA) is primarily known as a proapoptotic protease.
  • Its role in cell death and inflammation is not fully understood.

Purpose of the Study:

  • To investigate the mechanisms of GzmA-induced cell death.
  • To explore the non-catalytic functions of Granzymes in inflammation.

Main Methods:

  • Studied GzmA-induced cell death in synergy with perforin (PFN).
  • Assessed GzmA's effect on cytokine secretion in monocytic cells.
  • Utilized GzmA knockout mice and GzmA-expressing cytotoxic T lymphocytes (CTLs).

Main Results:

  • GzmA induces rapid necrotic cell death through membrane damage, requiring synergy with sublytic PFN.
  • Both GzmA and Granzyme B (GzmB) mediate necrosis independently of catalytic activity.
  • GzmA stimulates monocytic cells to secrete IL-1beta, TNFalpha, and IL-6, blocked by caspase-1 inhibition.
  • Murine GzmA and CTLs induce IL-1beta in macrophages; GzmA knockout mice show resistance to LPS toxicity.

Conclusions:

  • Granzyme A has a dual role in inducing rapid cell death and promoting inflammation.
  • The granule secretory pathway is unexpectedly involved in inflammatory processes.
  • GzmA acts as an endogenous modulator of inflammation, independent of its protease function.